U.S. biotech firm Nabla Bio said on Tuesday it has signed a second major research partnership with Japanese drugmaker Takeda ...
Bristol Myers Squibb have extended their research collaboration aimed at designing and optimizing small-molecule drugs for ...
AI has advanced molecule design, yet synthetic feasibility remains a bottleneck. Chemistry-first approaches offer a practical ...
Discover the emerging field of AI-based peptide discovery and design – could this signal the beginning of a golden age for ...
Dianthus Therapeutics and Boehringer Ingelheim headlined the latest round of licensing d | Dianthus and Boehringer Ingelheim ...
When I first realized the scale of the challenge posed by neurodegenerative diseases, such as Alzheimer's, Parkinson's ...
Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.
An AI agent is a software program that can interact with this environment, collect data and then use that information to perform self-determined tasks to meet a predetermined goal. But it’s not linear ...
Parexel, a clinical research organization (CRO) providing clinical and consulting solutions to the life sciences industry, has opened its new global headquarters in Raleigh’s North Hills Innovation ...
Microsoft warns of AI-powered cyber attacks. Microsoft warned in its annual digital threats report that Russia, China, Iran, ...
Even if the cuts were reversed today, former OSTP Director Arati Prabhakar said the Trump administration’s “destruction” will ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback